News
Article
Author(s):
Incyte announces 2024 Ingenuity Awards and Innovators Program, empowering vitiligo advocates and enhancing patient care through innovative initiatives.
Image Credit: © Drobot Dean - stock.adobe.com
This week, Incyte announced the 2024 recipients of 2 flagship initiatives—The Incyte Ingenuity Awards in Vitiligo (IIA) and the inaugural Vitiligo Innovators Program (VIP)—both of which aim to recognize and empower individuals and organizations improving the lives of those affected by vitiligo.1
Vitiligo, impacting approximately 1% of the global population, often leads to significant psychosocial burdens for patients due to visible changes in skin appearance and the social stigma associated with them.2 With limited FDA-approved treatment options until recent years, patient support, education, and advocacy remain key components of comprehensive care.
"Incyte is deeply committed to standing with the vitiligo community every step of the way - not only by advancing scientific innovation, but by elevating the voices, ideas and experiences of those most impacted by the condition," said Matteo Trotta, MBA, Executive Vice President and General Manager, US Dermatology, Incyte, in a news release. "We are proud to support this year's recipients as they drive change, offer support and create new paths toward understanding, acceptance and care."
2024 Incyte Ingenuity Awards: Strengthening Access and Advocacy
In its fourth year, the Incyte Ingenuity Awards in Vitiligo continue to support initiatives that aim to address unmet needs in advocacy, education, and access to care. In 2024, Incyte selected 2 award recipients for their impactful and forward-thinking projects.
“This opportunity allows our community to learn how to advocate for themselves and others on a broader scale,” said Valarie Molyneaux, President and CEO of VITFriends, in the release. “It’s about turning lived experience into action that can change laws, minds, and lives.”
“Our work focuses on the whole person, not just the condition,” said MD/MPH student Hannah Metheny and dermatologist Tali Czarnowicki, MD, in the release. “By understanding what stands in the way of psychosocial care, we hope to open doors for more compassionate, comprehensive treatment.”
Vitiligo Innovators Program: Elevating Leadership and Compassion
Launched in 2024, the Vitiligo Innovators Program (VIP) recognizes individual contributors in clinical care, research, and grassroots advocacy who have demonstrated exceptional commitment to the vitiligo community.
“This recognition is not mine alone—it belongs to every person with vitiligo who has shared their story and inspired this work,” Huggins said in the release.
“We’re learning more every day about this complex disease, and I’m honored to be part of a future where care is more precise, more inclusive, and more hopeful,” she said in the release.
“Living with vitiligo has shaped my purpose,” Molyneaux shared. “This award fuels our mission to create a world where people with vitiligo are seen, heard, and celebrated.”
Looking Ahead: Supporting a More Inclusive Future
Applications for the 2025 IIA and VIP awards are now open through October 31, 2025. The programs invite submissions from individuals and organizations who are driving innovative, equitable, and compassionate change in the vitiligo space. Entries are reviewed by a judging panel comprising clinicians, advocates, and community leaders including Erika Page (Living Dappled), Melissa Hughley (Patient Advocate), Richard Huggins, MD (Henry Ford Hospital), Heli Patel, MD, MBA (Thomas Jefferson University), and Heather Woolery-Lloyd, MD, FAAD (University of Miami; Founder of DermFriends).
For more information or to submit applications, visit: www.incyteingenuityawards.com/vitiligo and www.vitiligoinnovatorsprogram.com.
References
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.